Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis DeutschlandfiledCriticalSanofi Aventis Deutschland
Priority to DO2007000140ApriorityCriticalpatent/DOP2007000140A/en
Publication of DOP2007000140ApublicationCriticalpatent/DOP2007000140A/en
La presente invención se refiere a mecanismos accionadores adecuados para usarse en dispositivos de descarga de fármacos, en particular inyectores de tipo pluma estilográfica, con los que pueden administrarse varias dosis preajustadas de un producto medicinal. En particular, la presente invención se refiere a tales dispositivos de descarga de fármacos en los que un usuario puede activar el dispositivo de descarga de fármacos.The present invention relates to actuator mechanisms suitable for use in drug discharge devices, in particular pen-type injectors, with which several preset doses of a medicinal product can be administered. In particular, the present invention relates to such drug discharge devices in which a user can activate the drug discharge device.
DO2007000140A2007-11-162007-11-16
IMPROVEMENTS IN AND RELATED TO SUITABLE ACTUATING MECHANISMS FOR USE IN PHARMACOS UNLOADING DEVICES.
DOP2007000140A
(en)
Use of a pharmaceutical composition comprising treprostinil for the preparation of a medicament for the treatment or prevention of a condition associated with cystic fibrosis.
Pharmaceutical combination comprising a glp-1 receptor agonist and linagliptin, dpp-4 inhibitor; use of the pharmaceutical combination for the treatment of type 2 diabetes and obesity.